Clinical Outcomes of the Freedom Spinal Cord Stimulation (SCS) System for the Management of Chronic Back and Leg Pain
TerminatedNot applicableNCT02403518
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates the Freedom SCS (spinal cord stimulation) System for the treatment of chronic back and leg pain. Patients who have been diagnosed with failed back surgery syndrome (FBSS) will receive a stimulator device for treatment of their pain.
Study details
- Official title
- A Prospective, Multi-National, Post-Marketing Study of the Clinical Outcomes of Wireless Neuromodulation Via the Freedom Spinal Cord Stimulation (SCS) System for the Management of Chronic Back and Leg Pain
- Conditions
- Chronic Low Back Pain
- Pain in Leg, Unspecified
- Interventions
- Device: Freedom Spinal Cord Stimulator System
- Sponsor
- Curonix LLC
- Collaborators
- Amphia ziekenhuis, Oosterhout, The Netherlands
- Start date
- 2016-10
- Primary completion
- 2020-09
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Netherlands
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Appropriate Freedom SCS candidate as affirmed by study investigator * Candidate has a stable spine not suitable for further surgery as confirmed by physician * 18 years of age or older (no upper age limit) * Diagnosis of failed back surgery syndrome (FBSS) characterized by chronic, intractable pain of the legs, back, or both legs and back * At least 6 months since last surgical procedure on the spine * Average score of 60mm or greater on a VAS scale (Scale of 0 to 100, where 0 equals no pain and 100 equals worst possible pain) * Pain duration of at least 6 months * Expected lifespan of at least two years * Able to comply with study requirements * Gives informed consent for study participation Exclusion Criteria: * A consistent VAS score of 100 over the past 24 hours as established at Visit 1 * A co-existing condition that could increase the risk of SCS implantation (e.g., severe cardiac or respiratory disorders, coagulation disorder) or planned surgery within the study duration that could be compromised by SCS (e.g., diathermy) * Pregnant or planning to become pregnant * Known or suspected substance abuse within the last 2 years * Major psychiatric disorder (untreated or refractory to treatment) in the investigators opinion * Cognitive and/or behavioral issues that could impair study participation, (e.g., unreliability; defective memory; noncompliance in taking medications or keeping appointments; or impaired orientation to time, place, and events) * Documented allergy to Freedom SCS material components * Co-existing pain condition or participation in another clinical study that could confound the results of this study * History of another implanted medical device (e.g., explanted spinal cord stimulator, peripheral nerve stimulation, sacral nerve stimulator, pacemaker, or intrathecal drug delivery)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02403518